Company Search:
Advanced Search
Sponsored Links
Aptinyx Inc Company Snapshot
Aptinyx Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aptinyx Inc with three other companies in this sector in the United States: ProQR Therapeutics NV (2018 sales of $6.79 million of which 100% was Pharmaceutical), Dicerna Pharmaceuticals Inc ($6.18 million of which 100% was RNA Interference (RNAi) Therapeutics), and US Stem Cell Inc ($6.70 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aptinyx Inc
  Stock Performance Chart for Aptinyx Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 3.09
(Figures in U.S. Dollars)
1 Week -5.8%   13 Weeks -23.1%  
4 Weeks -17.6%   52 Weeks -88.3%  
Aptinyx Inc Key Data:
  Ticker: APTX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 6,574,000
(Year Ending Jan 2019).
Employees: 63
  Currency: U.S. Dollars Market Cap: 103,848,720
  Fiscal Yr Ends: December Shares Outstanding: 33,608,000
  Share Type: Common Closely Held Shares: 6,637,789
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.